NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 430 filers reported holding NOVAVAX INC in Q4 2021. The put-call ratio across all filers is 1.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $169,025 | -6.0% | 23,346 | -3.5% | 0.00% | 0.0% |
| Q2 2023 | $179,836 | +14.1% | 24,204 | +6.4% | 0.00% | 0.0% |
| Q1 2023 | $157,630 | -30.5% | 22,746 | +3.1% | 0.00% | -50.0% |
| Q4 2022 | $226,880 | -41.2% | 22,070 | +3.9% | 0.00% | -50.0% |
| Q3 2022 | $386,000 | -63.7% | 21,233 | +2.7% | 0.00% | -60.0% |
| Q2 2022 | $1,063,000 | -27.8% | 20,673 | +3.4% | 0.01% | -16.7% |
| Q1 2022 | $1,473,000 | -46.6% | 19,994 | +3.8% | 0.01% | -42.9% |
| Q4 2021 | $2,756,000 | -32.7% | 19,266 | -2.5% | 0.02% | -36.4% |
| Q3 2021 | $4,095,000 | -2.8% | 19,754 | -0.4% | 0.03% | -2.9% |
| Q2 2021 | $4,211,000 | +25.3% | 19,832 | +7.0% | 0.03% | +17.2% |
| Q1 2021 | $3,360,000 | +69.5% | 18,532 | +4.3% | 0.03% | +61.1% |
| Q4 2020 | $1,982,000 | +4.6% | 17,771 | +1.6% | 0.02% | -5.3% |
| Q3 2020 | $1,895,000 | +95.6% | 17,488 | +50.4% | 0.02% | +35.7% |
| Q2 2020 | $969,000 | – | 11,630 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 66,810 | $13,850,000 | 10.84% |
| Parametrica Management Ltd | 60,296 | $12,484,000 | 9.33% |
| RA Capital Management | 2,097,794 | $434,894,000 | 6.03% |
| Foresite Capital Management II, LLC | 67,373 | $13,967,000 | 4.96% |
| Samsara BioCapital, LLC | 82,600 | $17,124,000 | 2.69% |
| Rock Springs Capital Management LP | 455,000 | $94,326,000 | 1.98% |
| Tri Locum Partners LP | 19,300 | $4,001,000 | 1.59% |
| SECTORAL ASSET MANAGEMENT INC | 89,450 | $18,544,000 | 1.54% |
| Foresite Capital Management III, LLC | 5,000 | $1,037,000 | 1.44% |
| TSP Capital Management Group, LLC | 18,525 | $3,840,000 | 1.31% |